Durable Physiological Changes and Decreased Syncope Burden 12 Months After Unifocal Right-Sided Ablation Under Computed Tomographic Guidance in Patients With Neurally Mediated Syncope or Functional Sinus Node Dysfunction

Philippe Debruyne, Tom Rossenbacker, Luc Janssens, Christine Collienne, Joris Ector, Peter Haemers, Jean-Benoît le Polain de Waroux, Christine Bazelmans, Tim Boussy, William Wijns, Philippe Debruyne, Tom Rossenbacker, Luc Janssens, Christine Collienne, Joris Ector, Peter Haemers, Jean-Benoît le Polain de Waroux, Christine Bazelmans, Tim Boussy, William Wijns

Abstract

[Figure: see text].

Trial registration: ClinicalTrials.gov NCT02954666.

Keywords: autonomic nervous system; cohort studies; exercise test; heart rate; syncope.

Figures

Figure 1.
Figure 1.
Computed tomography (CT) scan images and electroanatomical map indicating the region targeted during cardioneuromodulation (CardNM). CT scan images (A–E) and electroanatomical map (F) indicating the region targeted during CardNM. A, Red line delineating the mid and caudal parts of the right superior pulmonary vein antrum in an anteroposterior projection. B and C, Target line guiding CardNM indicated by the white line facing the first design line at the superior vena cava (SVC)–right atrium (RA) junction in a modified left anterior oblique (B) and cranial (C) projection. D, Transversal slice at the midportion of the target line showing the location and thickness of the fat pad containing the anterior right ganglionated plexus (ARGP) at this level (blue asterisk). E and F, Ablation tags along the target line in a posteroanterior CT scan view (E) and on the electroanatomical map (F) in the same projection after merging the two images. The region of the ARGP ablated is indicated by 2 green arrows. Each individual ablation is indicated using a colored tag. The phrenic nerve is tagged with black dots. CS indicates coronary sinus; IVC, inferior vena cava; LA, left atrium; RAA, right atrial appendage; RIPV, right inferior pulmonary vein; and RSPV, right superior pulmonary vein.
Figure 2.
Figure 2.
Syncope-free survival curves. CardNM indicates cardioneuromodulation.
Figure 3.
Figure 3.
Syncope burden at 3, 6, and 12 mo before and after cardioneuromodulation (CardNM). Each patient is represented by a different color.
Figure 4.
Figure 4.
Basal heart rate (HR) and HR after atropine injection. Basal HRs are represented by red violin plots. Reset basal HRs after ablation and 1 d later are represented by pale-red violin plots. Corresponding HRs after atropine are shown by the blue and pale-blue violin plots. The median value is mentioned for each violon plot by a horizontal line. The number of patients involved (X–X) and level of the median HR modification compared with baseline (%) are shown. HR acceleration (upward arrows) or deceleration (downward arrows) were all significant compared with baseline (P<0.001). The median basal HR at M6 and M12 was comparable with the postprocedural basal HR while the median basal HR at M1 was significantly higher (purple arrow; P<0.001). D indicates day; and M, month.
Figure 5.
Figure 5.
Mean heart rate (HR) during 24-h rhythm registration of patients with a mean HR at baseline under or above 70 beats per minute (bpm) at baseline, M1, M6, and M12. The blue violin plots indicate patients with a mean HR at baseline <70 bpm, and the light blue violin plots indicate these with a mean HR ≥70 bpm. The data are presented at baseline, M1, M6, and M12. The median values are indicated by the horizontal line in each violin plot. The level of HR acceleration compared with baseline is indicated in percentage. Significant values (P<0.001) compared with baseline are indicated by arrows. M indicates month.

References

    1. Shen WK, Sheldon RS, Benditt DG, Cohen MI, Forman DE, Goldberger ZD, Grubb BP, Hamdan MH, Krahn AD, Link MS, et al. . 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2017;136:e25–e59. doi: 10.1161/CIR.0000000000000498
    1. Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, Fedorowski A, Furlan R, Kenny RA, Martin A, et al. . 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39:1883–1948.
    1. Pachon JC, Pachon EI, Pachon JC, Lobo TJ, Pachon MZ, Vargas RN, Jatene AD. “Cardioneuroablation”–new treatment for neurocardiogenic syncope, functional AV block and sinus dysfunction using catheter RF-ablation. Europace. 2005;7:1–13. doi: 10.1016/j.eupc.2004.10.003
    1. Pachon JC, Pachon EI, Cunha Pachon MZ, Lobo TJ, Pachon JC, Santillana TG. Catheter ablation of severe neurally meditated reflex (neurocardiogenic or vasovagal) syncope: cardioneuroablation long-term results. Europace. 2011;13:1231–1242. doi: 10.1093/europace/eur163
    1. Yao Y, Shi R, Wong T, Zheng L, Chen W, Yang L, Huang W, Bao J, Zhang S. Endocardial autonomic denervation of the left atrium to treat vasovagal syncope: an early experience in humans. Circ Arrhythm Electrophysiol. 2012;5:279–286. doi: 10.1161/CIRCEP.111.966465
    1. Aksu T, Golcuk E, Yalin K, Guler TE, Erden I. Simplified crdioneuroablation in the treatment of reflex syncope, functional AV block, and sinus node dysfunction. Pacing Clin Electrophysiol. 2016;39:42–53.
    1. Sun W, Zheng L, Qiao Y, Shi R, Hou B, Wu L, Guo J, Zhang S, Yao Y. Catheter ablation as a treatment for vasovagal syncope: long-term outcome of endocardial autonomic modification of the left atrium. J Am Heart Assoc. 2016;5:e003471.
    1. Rivarola EW, Hachul D, Wu T, Pisani C, Hardy C, Raimundi F, Melo S, Darrieux F, Scanavacca M. Targets and end points in cardiac autonomic denervation procedures. Circ Arrhythm Electrophysiol. 2017;10:e004638. doi: 10.1161/CIRCEP.116.004638
    1. Hu F, Zheng L, Liang E, Ding L, Wu L, Chen G, Fan X, Yao Y. Right anterior ganglionated plexus: the primary target of cardioneuroablation? Heart Rhythm. 2019;16:1545–1551. doi: 10.1016/j.hrthm.2019.07.018
    1. Zhao L, Jiang W, Zhou L, Wang Y, Zhang X, Wu S, Xu K, Liu X. Atrial autonomic denervation for the treatment of long-standing symptomatic sinus bradycardia in non-elderly patients. J Interv Card Electrophysiol. 2015;43:151–159. doi: 10.1007/s10840-015-9981-8
    1. Qin M, Zhang Y, Liu X, Jiang WF, Wu SH, Po S. Atrial ganglionated plexus modification: a novel approach to treat symptomatic sinus bradycardia. JACC Clin Electrophysiol. 2017;3:950–959. doi: 10.1016/j.jacep.2017.01.022
    1. Aksu T, Guler TE, Bozyel S, Golcuk SE, Yalin K, Lakkireddy D, Gopinathannair R. Medium-term results of cardioneuroablation for clinical bradyarrhythmias and vasovagal syncope: effects on QT interval and heart rate. J Interv Card Electrophysiol. 2021;60:57–68. doi: 10.1007/s10840-020-00704-2
    1. Debruyne P. “Cardio-neuromodulation” with a multielectrode irrigated catheter: a potential new approach for patients with cardio-inhibitory syncope. J Cardiovasc Electrophysiol. 2016;27:1110–1113.
    1. Debruyne P, Wijns W. Cardio-neuromodulation: the right-sided approach. JACC Clin Electrophysiol. 2017;3:1056–1057. doi: 10.1016/j.jacep.2016.12.027
    1. Debruyne P, Rossenbacker T, Collienne C, Roosen J, Ector B, Janssens L, Charlier F, Vankelecom B, Dewilde W, Wijns W. Unifocal right-sided ablation treatment for neurally mediated syncope and functional sinus node dysfunction under computed tomographic guidance. Circ Arrhythm Electrophysiol. 2018;11:e006604. doi: 10.1161/CIRCEP.118.006604
    1. Hanna P, Rajendran PS, Ajijola OA, Vaseghi M, Andrew Armour J, Ardell JL, Shivkumar K. Cardiac neuroanatomy - Imaging nerves to define functional control. Auton Neurosci. 2017;207:48–58. doi: 10.1016/j.autneu.2017.07.008
    1. Brignole M, Menozzi C, Del Rosso A, Costa S, Gaggioli G, Bottoni N, Bartoli P, Sutton R. New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification. Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge. Vasovagal Syncope International Study. Europace. 2000;2:66–76. doi: 10.1053/eupc.1999.0064
    1. Zaglia T, Mongillo M. Cardiac sympathetic innervation, from a different point of (re)view. J Physiol. 2017;595:3919–3930. doi: 10.1113/JP273120
    1. Grinsell D, Keating CP. Peripheral nerve reconstruction after injury: a review of clinical and experimental therapies. Biomed Res Int. 2014;2014:698256. doi: 10.1155/2014/698256
    1. Hou Y, Scherlag BJ, Lin J, Zhang Y, Lu Z, Truong K, Patterson E, Lazzara R, Jackman WM, Po SS. Ganglionated plexi modulate extrinsic cardiac autonomic nerve input: effects on sinus rate, atrioventricular conduction, refractoriness, and inducibility of atrial fibrillation. J Am Coll Cardiol. 2007;50:61–68. doi: 10.1016/j.jacc.2007.02.066
    1. Debruyne P. Letter by Debruyne Regarding Article, “Targets and end points in cardiac autonomic denervation procedures”. Circ Arrhythm Electrophysiol. 2017;10:e005261.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する